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Summary
Blood vessels function in the uptake, transport, and delivery
of gases and nutrients within the body. A key question is
how the central lumen of blood vessels develops within
a cord of vascular endothelial cells. Here, we demonstrate
that sialic acids of apical glycoproteins localize to apposing
endothelial cell surfaces and generate repelling electrostatic
fields within an endothelial cell cord. Both in vitro and in vivo
experiments show that the negative charge of sialic acids is
required for the separation of endothelial cell surfaces and
subsequent lumen formation. We also demonstrate that
sulfate residues can substitute for sialic acids during lumen
initiation. These results therefore reveal a key step in the
creation of blood vessels, the most abundant conduits in
the vertebrate body. Because negatively charged mucins
and proteoglycans are often found on luminal cell surfaces,
it is possible that electrostatic repulsion is a general prin-
ciple also used to initiate lumen formation in other organs.
Results and Discussion
Mucins and proteoglycans are found on the luminal side of
tubular organs in vertebrates, for example the gut, pancreas,
salivary gland, lung, kidney, and blood vessels [1–5]. In addi-
tion, these glycoproteins are found on the apical surfaces of
invertebrate tubular organs, such as the retina, tracheae, and
wing imaginal discs ofDrosophila melanogaster; the excretory
cells ofCaenorhabditis elegans; or themidgut of theAnopheles
mosquito [6–10]. Interestingly, epithelial and endothelial cells
express one such mucin, the CD34 sialomucin Podocalyxin/
gp135 (PODXL), at the cell-cell contact at the onset of lumen
formation (Figure 1) [1, 11, 12]. As with many mucins, the
CD34 sialomucin extracellular domain is decorated with oligo-
saccharides containing a large number of negatively charged
sialic acids [13]. Because the vascular lumen has previously
been shown to develop through separation of adjacent endo-
thelial cell (EC) surfacesduringboth vasculogenesis andangio-
genesis [1, 14–16], we examined whether sialic acids of apical*Correspondence: lammert@uni-duesseldorf.decell-surface proteins contribute an electrostatic repulsion to
initiate this process. We first analyzed the developing mouse
aorta (Figure 1), where a temporally and spatially defined tran-
sition from a nonlumenized EC cord to a lumenized tube takes
place [1]. We find that sialic acids, detected with the Tritricho-
monas mobilensis lectin [17], appear at the cell-cell contact
(Figures 1A and 1B) and colocalize with the apical marker
PODXL at the cell-cell contact and luminal cell surfaces (data
not shown). These data suggest that the sialic acids on apical
cell-surface proteins are positioned to separate apposing EC
surfaces from each other to initiate blood vessel lumen forma-
tion in the developing mouse embryo.
It was previously shown that sialic acids can be removed
from CD34 sialomucins by the enzymatic activity of neuramin-
idases, also known as sialidases [18]. To test whether sialic
acids are required for vascular lumen formation in vivo, we in-
jected neuraminidase into the mesenchyme of mouse
embryos at the onset of aortic lumen formation and allowed
these embryos to develop in whole-embryo culture (WEC)
(Figure 1) [1]. We found that the injection of neuraminidase
significantly reduced the presence of sialic acids at the endo-
thelial cell-cell contact (compare Figures 1A and 1B with
Figures 1E and 1F). More importantly, these neuraminidase-
treated embryos developed fewer lumenized aortae when
compared with controls (compare Figures 1C and 1D with Fig-
ures 1G and 1H). The only lumenized dorsal aortae to develop
were observed cranially and caudally, far away from the injec-
tion sites (data not shown).
Because sialic acids strongly contribute to the negative
charge of apical cell-surface proteins, we asked whether
the negative charges of the apposing EC surfaces were
required for vascular lumen formation. More precisely, we
first asked whether reintroduction of negative charge to the
neuraminidase-treated ECs could restore lumen formation
(Figure S1, available online). To this end, we injected dextran
sulfate into mouse embryos, a negatively charged molecule
that has been shown to bind to the apical cell surfaces of
injured ECs in vivo [19, 20]. In our developing mouse aorta
model, we showed that dextran sulfate binds to the
neuraminidase-treated apical cell surface of ECs (Figures
S1I–S1K) and that it restores aortic lumen formation despite
the absence of sialic acids (Figures S1I–S1M). In contrast,
uncharged dextran does not rescue aortic lumen formation
(Figures S1A–S1H). Importantly, neither treatment affected
the EC viability or the expression of PODXL, moesin, and
F-actin at the apical cell surface (Figure 1, Figure S1, and
data not shown).
Second, we asked whether neutralization of the negative
charge could inhibit lumen formation. We therefore injected
into mouse embryos the cationic protamine sulfate, which
was shown to neutralize the negative charge of sialic acids
[21]. This injection significantly reduced the sialic acid staining,
showing that protamine sulfate effectively masked the sialic
acids (compare Figures 1A and 1B with Figures 1I and 1J).
More importantly, vascular lumen formation was reduced
when compared to control (compare Figures 1C and 1D with
Figures 1K and 1L). Taken together, these data strongly
suggest that sialic acids and their negative charge are required
Figure 1. Removal of Sialic Acids or Neutralization of the Negative Charge Inhibits Blood Vessel Lumen Formation
Confocal images of transverse sections through the developing mouse dorsal aortae and quantification of blood vessel lumen formation.
(A–D) Effects of poly-DL-alanine (control), (E–H) neuraminidase, and (I–L) protamine sulfate on the localization of sialic acids and PODXL at the endothelial
cell-cell contact and on aortic lumen formation (asterisks).
(A, B, E, F, I, and J) Confocal images showing (A, E, and I) sialic acids or (B, F, and J) PODXL on transverse sections through dorsal aortae afterWECofmouse
embryos from the 2S to 2–3S stage for 30 min. Arrows point to the endothelial cell-cell contact.
(C, G, and K) Confocal images showing PECAM-1 endothelial staining on transverse sections through dorsal aortae after WEC from the 2S to 7S stage for
5–7 hr after the treatment indicated on the left. Arrowheads point to nonlumenized dorsal aortae, whereas asterisks mark the vascular lumen.
The following abbreviations are used: EC, endothelial cell; En, endoderm; NE, neuroepithelium. Scale bars represent 5 mm (A, B, E, F, I, and J) and 20 mm
(C, G, and K).
(D, H, and L) Quantification of EC cords (‘‘No Lumen,’’ white bar) and vascular tubes (‘‘Lumen,’’ black bar) after WEC from the 2S to 7S stage following the
treatment indicated on the left. nR 100 aortic sections of nR 3 embryos per condition. All values are means 6 SD.
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the developing mouse embryo.
We next investigated whether sialic acids and their negative
charge reduce adhesion of apposing EC surfaces (Figure 2). To
this end, we established a bead rolling assay (BRA) (Figure 2A)
in which human umbilical vein endothelial cells (HUVECs) ex-
pressing sialic acids at their apical EC surface were grown on
collagen I-coated beads and cell culture dishes (Figures 2A
and 2B and data not shown). The EC-covered beads were
then transferred to the tilted EC monolayer to determine their
rolling distance over time (Figure 2A). This distance is an
inverse measure for the adhesion of the apposing EC surfaces
because cell-cell adhesion is supposed to counteract gravity
and thus inhibits the rolling of the beads. Indeed, the rolling
distance of the beads increased with the steepness of the
cell culture dish (Figure 2J). Using theBRA,we found that neur-
aminidase-treated ECshad fewer sialic acids on their apical EC
surface (compare Figures 2A and 2B with Figures 2D and 2E,
and see Figure 2K) and rolled over a significantly shorter
distance compared to control (12% 6 4%, p < 0.01) (compareFigure 2C with Figure 2F and see Figure 2L and Movie S1).
Moreover, addition of dextran sulfate, but not dextran, partially
rescued the bead rolling, indicating that the negative charge
is required for reducing cell-cell adhesion (Figure S2 and
Movie S2). Furthermore, treatment with protamine sulfate
masked the sialic acids on apical EC surfaces (compare Fig-
ures 2A and 2B with Figures 2G and 2H, and see Figure 2K),
and the beads rolled over a shorter distance compared to
control (28% 6 5%, p < 0.001) (compare Figure 2C with
Figure 2I and see Figure 2L and Movie S1). Incubation of
washed HUVECs for 30 min and for 24 hr reversed the effects
of protamine sulfate and neuraminidase, respectively (Fig-
ure 2L). These results demonstrate that the negative charge
of sialic acids is required for reducing the adhesion between
apposing EC surfaces.
Next,wequantified theadhesion strengthbetweenapposing
ECs by using single-cell force spectroscopy (SCFS) (Figure 3),
which is based on atomic force microscopy (AFM) [22, 23].
Here, the EC surfaces were brought into contact with each
other and, after a dwell time of 1, 10, or 20 s, we recorded the
Figure 2. Sialic Acids and Negative Cell-Surface Charges Are Required for Deadhesion of Apposing Endothelial Cell Surfaces
(A, D, and G) Schematic diagram of a BRA experiment under (A) control conditions and after treatment with (D) neuraminidase or (G) protamine sulfate.
The negative charges of sialic acids are shown in green (2) and the positive charges of protamine sulfate are shown in red (+). A black arrow indicates
the rolling of the HUVEC-coated beads on the tilted HUVEC monolayer.
(B, E, and H) Confocal images of transverse sections through ECs grown on collagen I-coated beads and stained for sialic acids after the treatment indicated
on the left.
(C, F, and I) Bright-field images of movies showing EC-coated beads rolling on a tilted EC monolayer. Time is indicated in min:s. See also Movie S1.
Scale bars represent 5 mm (B, E, and H) and 100 mm (C, F, and I).
(J) Quantification of the rolling distance in relation to the steepness of the monolayer. nR 90 beads per angle (degree). All values are means 6 SD.
(K) Quantification of the fluorescence intensity of sialic acid staining on the surface of ECs grown on collagen I-coated beads after the treatment indicated
below. nR 10 beads per treatment. *p < 0.05. All values are means 6 SD.
(L) Quantification of the rolling distance of EC-coated beads on a tilted ECmonolayer directly after treatment (black bars), 30min after washing (gray bars), or
24 hr after washing (white bar). nR 300 beads per treatment from nR 3 independent experiments. *p < 0.05. All values are means 6 SEM.
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Figure 3. Quantification of Adhesion Forces between Apposing Endothelial Cell Surfaces after Neuraminidase and Protamine Sulfate Treatment by SCFS
(A–C) Schematic diagram of an adhesion experiment under (A) control conditions and after treatment with (B) neuraminidase or (C) protamine sulfate. The
negative charges of sialic acids are shown in green (2) and the positive charges of protamine sulfate are shown in red (+). An EC grown onto an AFM canti-
lever was brought into contact with the ECmonolayer. Black dashed lines indicate the laser beam tomeasure the cantilever deflection. After a given contact
time (1 , 10 , or 20 s), the cantilever was withdrawn to separate the ECs and to measure their adhesive forces. Black arrows indicate the adhesive force
between the single EC and the ECmonolayer causing the cantilever to deflect downward. The thickness of the arrow reflects the magnitude of the adhesive
strength between the cells.
(D–F) Representative force-distance curves (20 s) after treatment indicated above. Approach curves of the cantilevers toward the ECmonolayer are shown in
gray. Withdrawal curves are shown in black and are used to estimate the maximum adhesion force (arrow).
(G–I) Quantification of the adhesion force between ECs and an EC monolayer after 1 s (black bar), 10 s (gray bar), and 20 s (white bar) contact times and
treatment indicated above. n R 12 independent experiments with n R 56 measurements per condition and contact time. All values are means 6 SEM.
(H and I) Numbers on the bars indicate fold change compared to (G) control for the respective contact time.
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dase treatment increased endothelial cell-cell adhesion after
a contact time of 1 s (1.73 increase, p < 0.001 compared to
control), 10 s (2.13 increase, p < 0.001 compared to control),
and 20 s (2.93 increase, p < 0.001 compared to control)
(compare Figures 3A, 3D, and 3G with Figures 3B, 3E,
and 3H). Moreover, the low adhesion force between apposing
ECs could be restored by the addition of dextran sulfate but
not by the addition of uncharged dextran (Figure S3). ECs
treated with protamine sulfate also showed increasing cell-
cell adhesion (1 s: 1.63 increase; 10 s: 2.13; and 20 s: 2.33;p < 0.001 compared to control) (compare Figures 3A, 3D, and
3G with Figures 3C, 3F, and 3I), but 30 min after washing, the
low adhesion between ECs was restored at all contact times
(data not shown). Thus, these force measurements directly
confirm that ECs require the negative charge of sialic acids
for lowering the cell-cell adhesion.
Lastly, we tested whether sialic acids and negative cell-
surface charge were also required for lumen formation during
sprouting angiogenesis (Figure 4), a process shown to be
involved in blood vessel formation in the developing brain
and retina as well as in the growing tumor [24–27]. Here, we
Figure 4. Sialic Acids and Negative Cell-Surface Charges Are Required for Vascular Lumen Formation In Angiogenic Sprouts
(A, D, and G) Schematic overviews on lumen formation in angiogenic sprouts under (A) control conditions and after treatment with (D) neuraminidase or (G)
protamine sulfate. The negative charges of sialic acids are shown in green (2) and the positive charges of protamine sulfate are shown in red (+). The vascular
lumen is indicated in yellow.
(B, E, H) Bright-field images of angiogenic sprouts 26 hr after the treatment indicated on the left. The vascular lumen is pseudocolored in yellow. See also
Movie S3. Scale bars represent 20 mm.
(C, F, I) Quantification of lumen formation in sprouts 26 hr after the treatment indicated on the left. nR 35 sprouts from n = 6 experiments per treatment. All
values are means 6 SEM.
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which reflects in vivo angiogenesis to a large extent [29–31].
We identified the vascular lumen in these sprouts based on
bright-field and confocal light microscopic images. Using
this assay, we found that sprouts harboring a small lumen
developed into sprouts with virtually no vascular lumen upon
neuraminidase treatment (compare Figures 4A–4C with Fig-
ures 4D–4F, and see Movie S3). Importantly, lumen formation
was partially restored by the addition of dextran sulfate, but
not by the addition of uncharged dextran (Figure S4). In addi-
tion, sprouts treated with protamine sulfate also showed
a reduction in vascular lumen development (compare Figures
4A–4C with Figures 4G–4I, and see Movie S3). In both neur-
aminidase and protamine sulfate treatments, the apposing
apical EC surfaces appear to adhere for longer times and
thus have difficulties separating in order to form a continuous
and growing vascular lumen (Movie S3). Therefore, the nega-
tive charge of sialic acids is also required for lumen formation
in angiogenic sprouts in vitro.
Taken together, our findings show that the blood vessel
lumen develops from the electrostatic repulsion of apposing
EC surfaces. Because negatively charged glycoproteins,
such as mucins and proteoglycans, are found on most luminal
cell surfaces, such as the ones of tracheae, gut tubes, kidney
tubules, pancreatic ducts, and the tubes of testis and
mammary glands, it is possible that electrostatic repulsion is
a general principle used to initiate lumen formation in many
organs throughout the animal kingdom.
Experimental Procedures
Antibodies and Reagents
Goat anti-PODXL (R&D Systems), rat anti-PECAM-1 (BD Bioscience), rabbit
anti-moesin (Abcam), Alexa Fluor 488 phalloidin (Invitrogen), andbiotinylated T. mobilensis lectin [17] were used for immunostainings. DAPI
(Sigma)was used to stain cell nuclei. Secondary antibodieswere conjugated
with AF488, AF633 (Molecular Probes), Cy3, or Cy5 (Jackson Immuno-
Research). Neuraminidase (0.5U/ml, Sigma) or protamine sulfate (0.5mg/ml,
Sigma) was used for WEC, for BRA, and for SCFS experiments. Low-molec-
ular-weight dextran (Sigma) and dextran sulfate (Sigma) were used at
1 mg/ml for WEC and at 10 mg/ml for BRA and SCFS. FITC conjugated
dextran sulfate [32] was used at 1 mg/ml for labeling the neuraminidase-
treated apical cell surfaces of aortic ECs. For the 3D sprouting angiogenesis
assay, fibrinogen (2.5 mg/ml, Sigma), aprotinin (0.15 U/ml, Sigma), thrombin
(4 U/ml, Sigma), neuraminidase (0.06 U/ml), dextran and dextran sulfate
(0.05 mg/ml), and protamine sulfate (0.5 mg/ml) were used. Poly-DL-alanine
(0.5 mg/ml, Sigma) or PBS served as controls in each assay.Mouse Embryo Isolation, Embryonic Injections, and WEC
Isolated NMRI or CD1 mouse embryos (Janvier) were sorted by their
numbers of somites. All embryos, after isolation or WEC, were fixed in
4% paraformaldehyde (PFA) in PBS and further processed for imaging.
WEC was performed as previously described [1]. Briefly, all substances
were injected into embryos at the 2S stage from the ventral side through
the endoderm into the mesenchyme. After injection, embryos were roller-
cultured for the indicated time periods and processed for immunostaining
and imaging.Immunostaining and Imaging
Immunostaining and imaging were performed as previously described [1].
Images were acquired and analyzed with a Zeiss Laser Scanning Micro-
scope (LSM510 or LSM710) and ImageJ (National Institutes of Health,
[NIH]), respectively. For the identification of ECs, all sectionswere costained
for PECAM-1.Cell Culture
HUVEC (Lonza) at a passage smaller than passage 6 were used for all
experiments. HUVECs and human skin fibroblast cells (HSF Detroit 551,
Promochem) were grown in EGM-2 medium (Lonza) and MEM (supple-
mented with 10% FCS), respectively, and incubated at 37C and 5% CO2.
The media were changed every other day.
Current Biology Vol 20 No 22
2008Bead Rolling Assay
HUVECs were seeded on collagen I-coated Cytodex-3 beads (GE Health-
care) and collagen I-coated wells of a 6-well plate. On the second day,
w100 HUVEC-coated beads were transferred to each well containing
a confluent HUVECmonolayer, which was tilted byw20 degrees. The rolling
distance was subsequently recorded over 5 min (SMZ1500 and NIS-
elements, Nikon) at 30 frames/min. Neuraminidase or protamine sulfate
was subsequently added for 30 min, and the measurements were repeated.
In addition, the cells were subsequently washed with fresh medium and
incubated for 30 min or 24 hr, and rolling distances were then determined
with the BRA. Alternatively, dextran or dextran sulfate was added for
30 min to neuraminidase-treated cells, and measurements were repeated.
Rolling distances of the respective treatments were normalized to the
controls and analyzed with ImageJ (NIH).
SCFS
SCFS experiments were conducted by using AFM as previously described
[33]. In brief, HUVECs were cultured on a collagen I-coated coverslip. On
the second day, the confluent coverslips were carefully rinsed with EGM-2
medium and built into a BioCell (JPK Instruments) for measurements at
a physiological temperature (37C) and JPK NanoWizard equipped with
a CellHesion module (JPK Instruments) for long-distance pulling. Next,
50 ml of a single-cell suspension (w500 cells) was added into the BioCell,
and a single cell was picked with a Concanavalin A-coated tipless AFM
cantilever (NP-0, nominal spring constant 60 mN/m; Veeco Instruments)
using a constant contact force of 1 nN. Adhesion measurements were
carried out with an approach and retract velocity of 5 mm/s, a contact force
of 1 nN, and a contact time randomly changed between 1, 10, and 20 s at
different spots of the underlying monolayer. Force-distance curves were
analyzed with custom procedures in IgorPro (Wavemetrics [23]). Before
each experiment, spring constant measurements were performed on
undecorated glass slides with the thermal noise method [34].
3D Sprouting Angiogenesis Assay
The 3D sprouting angiogenesis assay was performed as previously
described [28]. Briefly, collagen I-coated Cytodex-3 beads were coated
with HUVECs. On the next day, beads were resuspended in PBS contain-
ing fibrinogen and aprotinin and mixed with thrombin to yield a fibrin
hydrogel. The solidified fibrin gel was subsequently overlaid with human
skin fibroblasts (ATCC). PBS (control), neuraminidase, dextran, dextran
sulfate, or protamine sulfate was added when a vascular lumen started
to develop, and sprouts were imaged on an inverted microscope (Zeiss
Axio Observer Z1) every 20 min for 26 hr. Per condition, six independent
wells were imaged with five fields of view per well. Sprouts of a minimal
length of 50 mm were counted at the end of the treatment period and clas-
sified as lumenized if more than 10% of the sprout length contained
a visible lumen (measured from sprout stalk to sprout tip, starting at
20 mm distance from the bead). Sprout lumens were detected on the cor-
responding bright-field image as previously shown [31] and pseudocol-
ored in yellow.
Statistical Analysis
Data are presented as mean 6 standard deviation (SD) or 6 standard error
of the mean (SEM) (see figure legends). Student’s t tests were used for
statistical analyses. p < 0.05 was considered statistically significant.Supplemental Information
Supplemental Information includes four figures and three movies and can
be found with this article online at doi:10.1016/j.cub.2010.09.061.
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